KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Acquisitions (2019 - 2024)

Elanco Animal Health (ELAN) has disclosed Acquisitions for 5 consecutive years, with $36.0 million as the latest value for Q4 2024.

  • Quarterly Acquisitions changed N/A to $36.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $41.0 million through Dec 2024, up 115.79% year-over-year, with the annual reading at $41.0 million for FY2024, 115.79% up from the prior year.
  • Acquisitions hit $36.0 million in Q4 2024 for Elanco Animal Health, up from $5.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $5.0 billion in Q3 2020 to a low of -$73.0 million in Q1 2021.
  • Historically, Acquisitions has averaged $771.9 million across 4 years, with a median of $16.0 million in 2023.
  • Biggest five-year swings in Acquisitions: tumbled 91.7% in 2021 and later tumbled 68.75% in 2024.
  • Year by year, Acquisitions stood at $5.0 billion in 2020, then crashed by 91.7% to $415.0 million in 2021, then plummeted by 99.28% to $3.0 million in 2023, then soared by 1100.0% to $36.0 million in 2024.
  • Business Quant data shows Acquisitions for ELAN at $36.0 million in Q4 2024, $5.0 million in Q1 2024, and $3.0 million in Q3 2023.